Loading data for ECOR — first visit, this takes a few seconds.

Alerte

electroCore Inc. (ECOR)

NasdaqCM: ECOR · Prix en temps réel · USD

10.53

+0.26 (2.53%)

À la clôture : Aug 18, 2026, 3:59 PM

2.53% (1D)

Cours acheteur	7.46
Capitalisation boursière	92.95M
Chiffre d’affaires (ttm)	36.97M
Résultat net (ttm)	-14.77M
Bêta	0.94
EPS (ttm)	-1.65
Ratio P/E (ttm)	n/a
P/E prévisionnel	-18.75
P/B (ttm)	-33.26
P/S (ttm)	2.51
Earnings Date	Nov 4, 2026

Cours vendeur	13.45
Volume	14,445
Volume moy. (20D)	119,514
Ouverture	10.35
Clôture précédente	10.27
Fourchette du jour	9.85 - 10.66
Intervalle de 52 semaines	4.41 - 10.68
Analyste	n/a
Objectif de prix	n/a
Dividendes	n/a
Date ex-dividende	n/a

À propos de ECOR

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of ...

[En savoir plus]

Industrie Medical Devices

Secteur Healthcare

Date d’introduction Jun 22, 2018

Employés 83

Bourse NasdaqCM

Symbole boursier ECOR

Site web https://www.electrocore.com

Profil complet de l’entreprise

Performance financière

En 2025, le chiffre d’affaires de electroCore s’élevait à 32.03M, soit une hausse de 27.2% par rapport aux 25.18M de l’année précédente. Le bénéfice s’élevait à -13.97M, soit une hausse de 17.5%.

États financiers

Surprise sur les résultats

electroCore a publié ses résultats trimestriels le Aug 6, 2026 :

Chiffre d’affaires de $9.45M est inférieur aux estimations de $0, avec 28.03% croissance en glissement annuel.

EPS de -0.33 dépasse les estimations de 0.09, avec 25.00% croissance en glissement annuel.

Prochaine publication des résultats

electroCore Inc. devrait publier ses résultats le Nov 4, 2026, pendant les heures de marché.
Les analystes prévoient un chiffre d’affaires de ... Passer à l’offre supérieure

Actualités

1 semaine il y a · MarketBeat

electroCore Q2 Earnings Call Highlights

electroCore (NASDAQ:ECOR) reported second-quarter 2026 revenue of $9.5 million, up approximately 28% from $7.4 million a year earlier, as growth in Veterans Affairs prescription sales and direct-to-co...

1 semaine il y a · Zacks

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of +19.51% and +0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2 semaines il y a · Zacks

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -3.30% and +14.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

3 mois il y a · MarketBeat

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore (NASDAQ:ECOR) Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health...

3 mois il y a · Motley Fool

electroCore (ECOR) Q1 2026 Earnings Transcript

Thomas Errico: Good afternoon, everyone, and thank you for joining electroCore, Inc.'s first quarter 2026 earnings call. This is the first earnings call since we announced our leadership transition, ...

Page 1 de 2

electroCore Inc. (ECOR)